⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811 | 0.96 | — | — | |
| SCHEMBL9292699 | 0.96 | — | — | |
| SCHEMBL6369906 | 0.96 | TSHR (0.50) | — | |
| Barium SCHEMBL11668415 | 0.92 | — | — | |
| SCHEMBL3441314 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL9903410 | 0.92 | — | — | |
| SCHEMBL8157610 | 0.92 | — | — | |
| Phosphine SCHEMBL20135762 | 0.92 | — | — | |
| Pentane SCHEMBL9455374 | 0.92 | TSHR (0.58) | — | |
| SCHEMBL625170 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673137-A1 | NBD1 MODULATORS AND METHODS OF USING THE SAME | Sionna Therapeutics Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2025124698-A1 | ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-06-19 | — | — | WO | disclosed |
| US-12336362-B2 | Diamondoid compounds | MERCK PATENT GMBH (DE) | 2025-06-17 | — | — | US | disclosed |
| WO-2024182736-A1 | NBD1 MODULATORS AND METHODS OF USING THE SAME | SIONNA THERAPEUTICS INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-3966871-B1 | DIAMONDOID COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-05-03 | — | — | EP | disclosed |
| WO-2022242724-A1 | NITROGEN-CONTAINING COMPOUND, CONJUGATE CONTAINING SAID COMPOUND, AND APPLICATION THEREOF | 上海迪诺医药科技有限公司 | 2022-11-24 | — | — | WO | disclosed |
| US-20220209150-A1 | DIAMONDOID COMPOUNDS | MERCK PATENT GMBH (DE) | 2022-06-30 | — | — | US | disclosed |
| EP-3966871-A1 | DIAMONDOID COMPOUNDS | Merck Patent GmbH (DE) | 2022-03-16 | — | — | EP | disclosed |
| WO-2020225270-A1 | DIAMONDOID COMPOUNDS | MERCK PATENT GMBH (DE) | 2020-11-12 | — | — | WO | disclosed |
| CN-202785614-U | Butyl lithium taking device | ASTATECH CHENGDU PHARMACEUTICAL CO LTD | 2013-03-13 | — | — | CN | disclosed |
| US-4868205-A | ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS | WARNER-LAMBERT COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
| US-4868195-A | ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY | WARNER-LAMBERT COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
| US-4868200-A | LEUKOTRIENES, LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
| US-4868199-A | ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY | WARNER-LAMBERT COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
| EP-0085959-B1 | AROMATIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1989-04-19 | — | — | EP | disclosed |
| EP-0300797-A1 | Pesticidal compounds | ROUSSEL UCLAF (FR) | 1989-01-25 | — | — | EP | disclosed |
| US-4761424-A | Enolamides, pharmaceutical compositions and methods for treating inflammation | WARNER-LAMBERT COMPANY (US) | 1988-08-02 | — | — | US | disclosed |
| EP-0249950-A1 | Aromatic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-12-23 | — | — | EP | disclosed |
| EP-0221345-A1 | Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade | WARNER-LAMBERT COMPANY (US) | 1987-05-13 | — | — | EP | disclosed |
| EP-0085959-A2 | Aromatic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1983-08-17 | — | — | EP | disclosed |